News
Filters
Showing 1 - 8 out of 8 results
News
KCTV: Skin Cancer Is the Most Common Type of Cancer. Here's How You Can Help Prevent It.
Skin cancer is the most common cancer in the United States, with an estimated 1 in 5 Americans developing skin cancer in their lifetime. This summer season, Megan McNally, MD, a fellowship-trained surgical oncologist with Saint Luke's Cancer Institute, joined KCTV to share helpful insights on skin safety.
Article
KCTV: Saint Luke's Celebrates 50 Year Anniversary of Clinical Forensic Program
Jennifer Sonsiadek, Nurse Manager of Saint Luke’s Clinical Forensic Program, talks to KCTV about how Saint Luke’s has been leading the way and innovating clinical forensic care provided in Kansas City and the nation for 50 years.
News
Health News You Can Use: Saint Luke's Clinical Forensics Program
The care a person receives immediately following abuse or assault has a significant effect on their physical, emotional, and psychological well-being.
News
CNN: Survival Rates Far Worse for Black Women After Bystander CPR, Study Finds
Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.
Article
USA Today: Black People, Women Less Likely to Survive After CPR for Cardiac Arrest
USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.
News
FDA Approves PulseSelect Pulsed Field Ablation System, a Novel Treatment for Atrial Fibrillation
Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.
News
diaTribe Learn: The Future of Cardiometabolic Care
Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.
News
KCTV: Atrial Fibrillation and New Treatment
Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.